Pacira Biosciences Inc (PCRX)

EBITDA Margin

15.38%

TTM · Period ending:

PCRX logo

PCRX EBITDA Margin

Latest reported15.38%
PCRX TTM EBITDA Margin (-125.03% → 15.38%)
High-resolution chart · PNG

PCRX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pacira Biosciences Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
15.3795%
16.112%
16.8641%
20.6226%
-0.1843%
3.9879%
4.154%
4.8094%
26.9433%
27.5035%
22.9022%
18.2686%
17.1865%
15.8053%
21.0519%
20.6343%
22.8496%
21.7827%
21.0419%
23.6902%
20.4079%
15.4514%
14.7828%
11.0314%
10.8742%
12.3039%
9.7585%
13.2329%
12.0565%
12.3989%
10.2847%
9.3251%
7.3569%
0.2829%
-3.695%
-8.1511%
-14.6365%
-11.9652%
-6.6299%
-6.3074%
1.9895%
3.9925%
5.0242%
8.6388%
7.3587%
6.5762%
2.183%
-8.6196%
-19.5071%
-33.8868%
-57.7029%
-83.7356%
-116.1023%
-118.751%
-108.1261%
-127.2918%
-123.2382%
-186.5199%
-208.72%
-193.5879%
-172.3738%
-154.1163%
-127.0018%
-123.1042%
-125.0331%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.